# Evaluation of the Riamet® Versus Malarone® in the Treatment of Uncomplicated Malaria

> **NCT01150344** · PHASE4 · COMPLETED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 317 (actual)

## Conditions studied

- Malaria

## Interventions

- **DRUG:** Malarone (atovaquone + proguanil combination)
- **DRUG:** RIAMET (artemether + LUMEFANTRIN combination)

## Key facts

- **NCT ID:** NCT01150344
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-07
- **Primary completion:** 2014-04
- **Final completion:** 2015-11
- **Target enrollment:** 317 (ACTUAL)
- **Last updated:** 2015-12-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01150344

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01150344, "Evaluation of the Riamet® Versus Malarone® in the Treatment of Uncomplicated Malaria". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01150344. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*